title: [Norplant contraception at the Rabta Tunis maternity hospital].
authors.forename: H
authors.initials: H
authors.lastname: Chelli
authors.forename: E
authors.initials: E
authors.lastname: Sfar
authors.forename: F
authors.initials: F
authors.lastname: Zouari
authors.forename: H
authors.initials: H
authors.lastname: Habibi
authors.forename: M
authors.initials: M
authors.lastname: Rouis
authors.forename: J
authors.initials: J
authors.lastname: Messaad
authors.forename: R
authors.initials: R
authors.lastname: Ouerghemmi
authors.forename: A
authors.initials: A
authors.lastname: Abed
authors.forename: M
authors.initials: M
authors.lastname: Khrouf
mesh_terms: D000349:Africa; D000352:Africa, Northern; D001695:Biology; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003906:Developing Countries; D003920:Diabetes Mellitus; D004194:Disease; D005193:Family Planning Services; D006331:Heart Diseases; D006973:Hypertension; D007774:Lactation; D016912:Levonorgestrel; D008599:Menstruation Disturbances; D008877:Middle East; D010827:Physiology; D011247:Pregnancy; D011446:Prospective Studies; D012106:Research; D012307:Risk Factors; D014416:Tunisia; D014652:Vascular Diseases
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D016912:Levonorgestrel
keywords: Africa; Arab Countries; Biology; Clinical Research; Contraception; Contraception Failure; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Implants; Contraceptive Methods; Contraceptive Usage; Developing Countries; Diabetes Mellitus; Diseases; Family Planning; French Speaking Africa; Heart Diseases; Hypertension; Lactation; Levonorgestrel--side effects; Maternal Physiology; Mediterranean Countries; Menstruation Disorders; Northern Africa; Physiology; Prospective Studies; Research Methodology; Research Report; Risk Factors; Studies; Tunisia; Vascular Diseases